131,164 Shares in Omega Healthcare Investors, Inc. (NYSE:OHI) Acquired by Zacks Investment Management

Zacks Investment Management acquired a new position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 131,164 shares of the real estate investment trust's stock, valued at approximately $5,338,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of OHI. Daiwa Securities Group Inc. increased its stake in Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust's stock worth $67,642,000 after buying an additional 1,274,238 shares during the period. Marshall Wace LLP bought a new stake in Omega Healthcare Investors during the 2nd quarter valued at $20,962,000. FMR LLC boosted its position in Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust's stock valued at $171,625,000 after buying an additional 380,626 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock worth $127,831,000 after acquiring an additional 272,299 shares during the last quarter. Institutional investors own 65.25% of the company's stock.

Insiders Place Their Bets

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Omega Healthcare Investors Stock Down 0.5 %

Shares of NYSE OHI traded down $0.18 on Friday, reaching $39.25. 1,322,275 shares of the company's stock traded hands, compared to its average volume of 1,804,351. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The business's 50 day simple moving average is $40.48 and its two-hundred day simple moving average is $37.69. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The company has a market cap of $10.60 billion, a price-to-earnings ratio of 28.86, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's payout ratio is 197.06%.

Analyst Upgrades and Downgrades

OHI has been the subject of several recent analyst reports. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research note on Monday, November 11th. Wells Fargo & Company reiterated an "overweight" rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research note on Wednesday, September 4th. BMO Capital Markets raised their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a research note on Monday, October 7th. Finally, BNP Paribas raised shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective on the stock in a research report on Thursday, October 31st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $40.18.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.